Tero Piispanen

Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in

Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland.

Kaiku Health Oy engages in the provision of digital health interventions for cancer patients. It offers patient-reported outcome monitoring and intelligent system tracking. The company was founded by Kaarlo Haikonen, Joel Lehikoinen, Henri Virtanen, Otto Seiskari and Lauri Sippola in 2012 and is headquartered in Helsinki, Finland.

Iktos SAS is a French start-up company specializing in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos is based in Paris, France, and has subsidiaries in France. The company offers generative modeling with built-in synthetic accessibility for successful drug discovery. The company's offerings include professional services, research collaborations & partnerships, and software & SaaS licenses. Iktos has developed a proprietary and innovative generative AI solution that enables the design of molecules optimized in silico for small molecule discovery projects. The company also has a unique AI-driven synthesis automation platform called Iktos Robotics. The company was founded in 2016 by Nicolas Do Huu, Quentin Perron, and Yann Gaston-Mathé, with Yann Gaston-Mathé serving as the CEO since then.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.